Stay updated on ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial
Sign up to get notified when there's something new on the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page.

Latest updates to the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page
- Check4 days agoChange DetectedA new revision entry v3.4.3 (2026-03-11) was added to the Record History, and the previous revision v3.4.2 (2025-12-30) was listed in deletions.SummaryDifference0.5%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedA new history entry Revision: v3.4.2 was added and Revision: v3.4.1 removed; there are no changes to study data or status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedAdded revision entry v3.4.1 to the record history and removed v3.4.0. This reflects an internal version update to the page rather than a change to the study data.SummaryDifference0.1%

- Check47 days agoChange DetectedUI enhancements to the study record history include a glossary display and color-coded change highlights (green for additions, red for deletions) with explanatory labels. The revision banner now shows Revision: v3.4.0, replacing the previous v3.3.4.SummaryDifference1%

- Check62 days agoChange DetectedNew revision entry v3.3.4 added and previous revision v3.3.3 removed from the history log. This reflects backend versioning changes and does not modify the study data or page functionality.SummaryDifference0.1%

- Check76 days agoChange DetectedRecord History now includes a new Study Status entry on 2025-12-30. The total number of Study Record Versions is updated to 11 on 2025-12-23, and a deletion occurred on 2025-10-01.SummaryDifference0.4%

Stay in the know with updates to ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page.